Vaccines to treat opioid use disorders and to reduce opioid overdoses

Carly Baehr; Marco Pravetoni

doi:10.1038/s41386-018-0197-3

Vaccines to treat opioid use disorders and to reduce opioid overdoses

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	217-218
Number of pages	2
Journal	Neuropsychopharmacology
Volume	44
Issue number	1
DOIs	https://doi.org/10.1038/s41386-018-0197-3
State	Published - Jan 1 2019

Bibliographical note

Funding Information:
This work is supported by a Hennepin Healthcare Research Institute award (M.P.), and by the NIH under grants U01 DA038876 (M.P.), R01 DA041730 (M.P.), and T32DA007097 (C.B.).Competing interests: M.P. is the inventor of “Cytokine Signaling Immunomodulators and Methods,” International Application No. PCT/US2017/031907 filed on May 10, 2017. C.B. declares no competing interests.

Funding Information:
This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Sorbonne Universités, and by grants from the Fondation pour la Recherche sur le Cerveau, the Fondation de France, the Région Ile-de-France, the Fondation pour la

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1038/s41386-018-0197-3

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235930

OpenUrl availability

Full text

Cite this

@article{1dfb051633894ccba3c58b70a255f83c,

title = "Vaccines to treat opioid use disorders and to reduce opioid overdoses",

author = "Carly Baehr and Marco Pravetoni",

note = "Funding Information: This work is supported by a Hennepin Healthcare Research Institute award (M.P.), and by the NIH under grants U01 DA038876 (M.P.), R01 DA041730 (M.P.), and T32DA007097 (C.B.).Competing interests: M.P. is the inventor of “Cytokine Signaling Immunomodulators and Methods,” International Application No. PCT/US2017/031907 filed on May 10, 2017. C.B. declares no competing interests. Funding Information: This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sant{\'e} et de la Recherche M{\'e}dicale, the Sorbonne Universit{\'e}s, and by grants from the Fondation pour la Recherche sur le Cerveau, the Fondation de France, the R{\'e}gion Ile-de-France, the Fondation pour la",

year = "2019",

month = jan,

day = "1",

doi = "10.1038/s41386-018-0197-3",

language = "English (US)",

volume = "44",

pages = "217--218",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Vaccines to treat opioid use disorders and to reduce opioid overdoses

AU - Baehr, Carly

AU - Pravetoni, Marco

N1 - Funding Information: This work is supported by a Hennepin Healthcare Research Institute award (M.P.), and by the NIH under grants U01 DA038876 (M.P.), R01 DA041730 (M.P.), and T32DA007097 (C.B.).Competing interests: M.P. is the inventor of “Cytokine Signaling Immunomodulators and Methods,” International Application No. PCT/US2017/031907 filed on May 10, 2017. C.B. declares no competing interests. Funding Information: This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Sorbonne Universités, and by grants from the Fondation pour la Recherche sur le Cerveau, the Fondation de France, the Région Ile-de-France, the Fondation pour la

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85056620922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056620922&partnerID=8YFLogxK

U2 - 10.1038/s41386-018-0197-3

DO - 10.1038/s41386-018-0197-3

M3 - Comment/debate

C2 - 30405185

AN - SCOPUS:85056620922

SN - 0893-133X

VL - 44

SP - 217

EP - 218

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 1

ER -

Vaccines to treat opioid use disorders and to reduce opioid overdoses

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this